Status:
COMPLETED
A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Osteoporosis
Vitamin D Deficiency
Eligibility:
All Genders
40-90 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to test the safety, tolerability, and effectiveness of an investigational drug and dietary supplement to reduce the risk of vitamin D insufficiency and deficiency during t...
Eligibility Criteria
Inclusion
- Men or postmenopausal women who are osteoporotic
Exclusion
- Vitamin D deficiency
- Other disease of bone or mineral metabolism
- Digestive disease causing malabsorption
- Other medical conditions that are not adequately treated
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2004
Estimated Enrollment :
652 Patients enrolled
Trial Details
Trial ID
NCT00092079
Start Date
January 1 2004
End Date
November 1 2004
Last Update
November 11 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.